During the past decade, Main Line Health Heart Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Main Line Health Heart Center" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Boston Scientific Corporation" with 2 trials sponsored, "Edwards Lifesciences" with 2 trials sponsored, "Advanz Pharma" with 1 trials sponsored and "Conformal Medical, Inc" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Main Line Health Heart Center" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Main Line Health Heart Center" are "Coronary Artery Disease" (4 trials), "Atrial Fibrillation" (2 trials), "Heart Failure" (2 trials), "Heart Valve Diseases" (2 trials) and "Tricuspid Valve Disease" (2 trials). Many other conditions were trialed in "Main Line Health Heart Center" in a lesser frequency.

Most popular intervention types in "Main Line Health Heart Center" are "Device" (10 trials), "Drug" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Optimal Medical Therapy" (2 trials), "ATS 3f Aortic Bioprosthesis" (1 trials), "CLAAS" (1 trials), "Carotid Artery Stenting" (1 trials) and "EDTA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Main Line Health Heart Center" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Main Line Health Heart Center". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Main Line Health Heart Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Main Line Health Heart Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".